For the first time, we demonstrated that an AET program can up-regulate the antiatherogenic eNOS-NO and nNOS-H2O2 pathways, which is associated with amelioration of endothelial function in a genetic model of hypercholesterolemia. The gene discussed is NOS1; the disease is Hypercholesterolemia.